Qiagen Sciences, LLC
48 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as Qiagen Waltham, Inc. (to 2018)
8
Ending by 2030
Feb 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 11, 2026The maintenance fee for DNA quality assessments using repetitive sequences (US 10,316,351) comes due Dec 11, 2026. Unpaid by Jun 11, 2027, it lapses early.
- 2 fees due Feb 15 to 18, 2027 · next Feb 15
- 1 fee due Mar 10, 2027The maintenance fee for Use of Amino Acid Sequences from Mycobacterium Tuberculosis or Corresponding Nucleic Acids for Diagnosis and Prevention of Tubercular Infection, Diagnostic Kit and Vaccine Therefrom (US 10,408,833) comes due Mar 10, 2027. Unpaid by Sep 10, 2027, it lapses early.
- 1 fee due Apr 20, 2027The maintenance fee for Microfluidic device (US 9,163,277) comes due Apr 20, 2027. Unpaid by Oct 20, 2027, it lapses early.
- 3 fees due May 14 to 21, 2027 · next May 14
- 1 fee due Jun 12, 2027The maintenance fee for TLR agonist-enhanced in vitro assay of cell mediated immune responsiveness (US 11,841,367) comes due Jun 12, 2027. Unpaid by Dec 13, 2027, it lapses early.
- 1 fee due Jul 28, 2027The maintenance fee for DNA quality assessments using repetitive sequences (US 10,544,447) comes due Jul 28, 2027. Unpaid by Jan 28, 2028, it lapses early.
- 2 fees due Aug 4 to 18, 2027 · next Aug 4
- 1 fee due Sep 3, 2027The maintenance fee for Diagnostic assay (US 10,578,612) comes due Sep 3, 2027. Unpaid by Mar 3, 2028, it lapses early.
- 1 fee due Oct 21, 2027The maintenance fee for Analyte Enrichment Methods and Compositions (US 10,626,446) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.
- 1 fee due Nov 19, 2027The maintenance fee for Screening asymptomatic pregnant woman for preterm birth (US 10,656,164) comes due Nov 19, 2027. Unpaid by May 19, 2028, it lapses early.
Recent changes
- 3 terms have ended since Aug 22, 2026
- Sep 16 US 8,834,694 Dry Compositions and Methods for Gel Electrophoresis · lapsed on the fee record
- Aug 30 US 7,846,315 Integrated bio-analysis and sample preparation system · term ended
- Aug 23 US 11,421,264 Thiol-Containing Cleave Reagents and Oxidative Wash · lapsed on the fee record
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,114,349 | Bio-analysis cartridge tracking and protection mechanism In force · USPTO record | In force | USPTO record | |
| US 8,500,980 | Method and apparatus for high speed genotyping In force · USPTO record | In force | USPTO record | |
| US 8,871,508 | Cell-mediated immune response assay and kits therefor In force · USPTO record | In force | USPTO record | |
| US 8,399,221 | Methods for detection and quantitation of small RNAs In force · USPTO record | In force | USPTO record | |
| US 9,012,149 | Methods for Detection and Quantitation of Small RNAs In force · Low confidence | In force | Low confidence | |
| US 8,597,938 | System for providing control reactions for real time RT-PCR In force · USPTO record | In force | USPTO record | |
| US 8,163,152 | Method and apparatus for high speed carbohydrate analysis In force · USPTO record | In force | USPTO record | |
| US 8,617,374 | Capillary electrophoresis using clear coated capillary tubes In force · USPTO record | In force | USPTO record | |
| US 9,040,002 | Microtiter Plate Mask In force · High confidence | In force | High confidence | |
| US 9,110,061 | Use of Amino Acid Sequences from Mycobacterium Tuberculosis or Corresponding Nucleic Acids for Diagnosis and Prevention of Tubercular Infection, Diagnostic Kit and Vaccine Therefrom In force · High confidence | In force | High confidence |
Also on record, not counted in the 55: 48 patents in force now held by others · 20 lapsed for an unpaid fee · 20 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
9 pending · 6 abandoned · 19 no status recorded
Rows 11 to 34 of 34 are for members. The first 10 are on the company page.
Pro members see all 34 published applications.